fb7777.ph
Dollar Tree CEO says ‘pressured’ Americans are hosting smaller parties to save money
Not Purdy: 49ers hit Green Bay with backup QB, no Bosa
South Korean President Yoon's impeachment vote fails after ruling party boycotts itWike, G5 governors want to destroy PDP – Rep member ugochinyereEXCLUSIVE: Tulsa King is still pulling its weight over at Paramount+ as Season 2 has become one of the three biggest domestic originals in the streaming service’s history. The second season, which wrapped up on November 17, has reached 13.6M global households to date, according to Paramount Global. It trails only behind Taylor Sheridan’s other hit 1923 and its own first season. (It’s common for Paramount+ to tout global households rather that viewers, since the company can’t determine how many people are watching via a single stream, or if anyone is actually watching at all.) This is a victory not only for Stallone and Sheridan, but for MTV Entertainment Studios and 101 Studios, which have been on a winning streak as of late. They also produce 1923 as well as Landman , which recently had the biggest global series premiere for Paramount+ in two years. The Sylvester Stallone-led series has been a force to be reckoned with since it returned to Paramount+ in September, setting an all-time viewership record on its premiere day. It’s no wonder the series is already likely on track for another two seasons . Paramount Global also says Season 2 has driven 159M views and 6.1M engagements on social media, up 894% and 553% respectively from the first season. In Tulsa King , Stallone stars as Dwight “The General” Manfredi, a fresh-out-of-prison mafia caporegime who establishes a new criminal empire in Oklahoma. In addition to Stallone, the series stars Martin Starr, Jay Will, Max Casella, Vincent Piazza, Tatiana Zappardino, Annabella Sciorra, Neal McDonough, Frank Grillo, Domenick Lombardozzi, Andrea Savage, Garrett Hedlund and Dana Delany. Tulsa King is executive produced by Taylor Sheridan, Oscar nominee Terence Winter, multi-award-nominated director Craig Zisk, David C. Glasser, Ron Burkle, Bob Yari, David Hutkin, Sylvester Stallone, Braden Aftergood and Keith Cox. The series is produced by MTV Entertainment Studios and 101 Studios.NEW YORK (AP) — Shortly before he was to be flogged and imprisoned for eight years, Mohammad Rasoulof fled Iran. Read this article for free: Already have an account? As we navigate through unprecedented times, our journalists are working harder than ever to bring you the latest local updates to keep you safe and informed. Now, more than ever, we need your support. Starting at $14.99 plus taxes every four weeks you can access your Brandon Sun online and full access to all content as it appears on our website. or call circulation directly at (204) 727-0527. Your pledge helps to ensure we provide the news that matters most to your community! NEW YORK (AP) — Shortly before he was to be flogged and imprisoned for eight years, Mohammad Rasoulof fled Iran. Read unlimited articles for free today: Already have an account? NEW YORK (AP) — Shortly before he was to be flogged and imprisoned for eight years, Mohammad Rasoulof fled Iran. His weekslong journey would take him from Tehran, through rural Iranian villages, on foot across a mountainous borderland and ultimately to Hamburg, Germany. As arduous and dangerous as the trip was, Rasoulof’s travels had an added wrinkle: He was trying to finish a movie at the same time. A week after arriving in Germany, Rasoulof would premiere his film, “The Seed of the Sacred Fig” at the Cannes Film Festival in France. As he fled, Rasoulof was preoccupied with the movie’s edit, which was being carried out in Germany. “I remember when I was sitting in the car that was driving me to the border,” Rasoulof says. “I had my laptop and I was taking notes and sending them to my editor. The two friends who were taking me kept saying, ‘Put that thing away for a second.’” In Cannes, “The Seed of the Sacred Fig” won a special jury prize and Rasoulof was celebrated with a 13-minute standing ovation. The movie has since been hailed as one of the best of the year, and arguably its most daring. Rasoulof made “Sacred Fig” clandestinely in Iran, directing scenes from a separate location to avoid raising suspicions. (The opening titles read: “When there is no way, a way must be made.”) Its story — a devastating family drama set during the 2022 protests that engulfed Iran — would surely only add to Rasoulof’s prison sentence. So after all of this, how is he feeling? When he recently met with The Associated Press for an interview, Rasoulof shrugged. “Ordinary,” he says. Rasoulof, 52, has a more gentle, bemused presence than some of his films would suggest. But how could Rasoulof, after what he’s lived through this year, feel anything like ordinary? “I still haven’t grasped the meaning of exile,” he explains. “I think it will take some time. The feeling of that void has not hit me yet, and I think it may never come.” Rasoulof has been busy traveling from film festival to film festival. In September, he and his 24-year-old daughter attended the Telluride festival in Colorado. Many more such stops were to come. Since fleeing Iran, Rasoulof has effectively been immersed in the world he’s long known: cinema. “Maybe I am living in the world of cinema, and maybe that’s why things are so familiar,” he agrees. “Maybe that’s why I don’t feel I’m in exile.” “The Seed of the Sacred Fig,” currently playing in theaters, is the Oscar submission from Rasoulof’s adoptive home, Germany. He’s settled in with his family, grateful for how the country has welcomed him. Speaking through an interpreter, Rasoulof grants that he’ll probably always mentally have a bag packed, ready to return to Iran should the chance ever come. But what “home” constitutes has changed for him. “I might be able to change this concept of home for myself,” he says. “I walk on the streets here and I see people of different colors and forms from all over the place, and they all call this place home. So there’s always the chance that one can build something new.” How oppressive politics can infiltrate the home is central to “The Seed of the Sacred Fig.” It concerns a family of four: Iman (Missagh Zareh), a lawyer newly appointed to the Revolutionary Court in Tehran; his wife, Najmeh (Soheila Golestani) and their two daughters, Rezvan (Mahsa Rostami) and Sana (Setareh Maleki). Iman is proud of his high position, but, when the government crackdown on protesters following the death of Mahsa Amini accelerates, his daughters are increasingly at odds with him. After Iman’s gun goes missing, his wife and daughters turn into suspects. “The Seed of the Sacred Fig,” populated with real cellphone videos from the protests, plays out as an excruciating microcosm of Iranian society. “It wasn’t like I put those videos in. They just came in,” says Rasoulof. “The reality is that it was through those videos I realized what happened. When the Woman, Life, Freedom movement occurred, I was in prison.” Rasoulof has spent several spells in Tehran’s Evin Prison. In 2010, he was arrested on set for filming without a permit. In 2022, he was jailed for seven months after pursuing the release of another of Iran’s most prominent filmmakers, Jafar Panahi. Panahi, who secretly made the film “No Bears,” was only released in 2023 after commencing a hunger strike. “My windows at home opened to the hills that have the Evin prison in them,” says Rasoulof. “I knew behind those walls many of my friends were sitting.” Rasoulof, inspired by the courage of the younger generation, resolved to pour the same spirit into “The Seed of the Sacred Fig.” Although it wasn’t until Rasoulof’s appeal of his sentence failed that he resolved to flee, he grants that deciding to make “Sacred Fig” essentially sealed his fate. “Making this film was part of that decision,” he says. “Although I had made up my mind earlier, because it was such a bitter decision, I was denying it and delaying it, waiting for a miracle to allow me to stay.” “I would open the fridge to make sure there was nothing there that would go bad,” he adds. “It was a strange circumstance.” For the film’s actors and crew members, signing up for the movie meant also becoming co-conspirators. Everyone knew the risks. And, like Rasoulof, many of them have since left Iran. Rostami and Maleki also now live in Germany. Asked if his collaborators are all currently safe, Rasoulof responds: “No one is safe from the Islamic Republic.” In his new life, Rasoulof is experiencing freedoms he never had in Iran. His films, for example, are widely available outside his native country but not in Iran. His prize-winning 2020 drama “There Is No Evil,” about capital punishment in Iran, is banned — though, ironically, Rasoulof’s prison guards enjoyed watching it with him from a flash drive. “I haven’t seen many of my films on a big screen, especially my last film,” he says. “I really want to see ‘There Is No Evil’ on a big screen. A festival in Portugal has promised to take me to see my own film.” The name of Rasoulof’s film comes from his memory of an ancient fig tree he once visited on an island in the south of Iran. It’s a tree that, with apparent metaphorical meaning for the Iranian government, spreads its seeds onto other trees, killing them and growing in their place. Rasoulof pulls out his phone to share a photo of his apartment in Tehran. Outside a large window, you can see the walls of Evin running along a craggy hillside. Inside are many houseplants. “This is my home,” he says. “I have a lot of plants. I really miss my plants. I have a neighbor who takes care of them for me. I actually have a fig tree at home.” Advertisement Advertisement
Nevada 90, Oklahoma St. 78
Prospera Financial Services Inc boosted its stake in iShares Core Total USD Bond Market ETF ( NASDAQ:IUSB – Free Report ) by 32.3% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 10,208 shares of the company’s stock after acquiring an additional 2,492 shares during the quarter. Prospera Financial Services Inc’s holdings in iShares Core Total USD Bond Market ETF were worth $481,000 as of its most recent filing with the SEC. Several other institutional investors and hedge funds also recently added to or reduced their stakes in IUSB. Vertex Planning Partners LLC lifted its holdings in iShares Core Total USD Bond Market ETF by 28.5% during the third quarter. Vertex Planning Partners LLC now owns 58,378 shares of the company’s stock valued at $2,751,000 after purchasing an additional 12,942 shares in the last quarter. Semus Wealth Partners LLC increased its position in shares of iShares Core Total USD Bond Market ETF by 81.1% during the third quarter. Semus Wealth Partners LLC now owns 21,325 shares of the company’s stock worth $1,005,000 after purchasing an additional 9,549 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new position in iShares Core Total USD Bond Market ETF in the 3rd quarter valued at $246,000. CAP Partners LLC lifted its holdings in iShares Core Total USD Bond Market ETF by 15.3% in the 3rd quarter. CAP Partners LLC now owns 39,409 shares of the company’s stock valued at $1,857,000 after purchasing an additional 5,218 shares in the last quarter. Finally, Theory Financial LLC boosted its stake in iShares Core Total USD Bond Market ETF by 34.8% during the 3rd quarter. Theory Financial LLC now owns 142,168 shares of the company’s stock worth $6,518,000 after purchasing an additional 36,677 shares during the last quarter. iShares Core Total USD Bond Market ETF Stock Performance IUSB opened at $45.61 on Friday. The firm’s 50-day moving average price is $46.29 and its 200 day moving average price is $45.97. iShares Core Total USD Bond Market ETF has a twelve month low of $44.21 and a twelve month high of $47.44. iShares Core Total USD Bond Market ETF Increases Dividend iShares Core Total USD Bond Market ETF Profile ( Free Report ) The iShares Core Total USD Bond Market ETF (IUSB) is an exchange-traded fund that is based on the Bloomberg U.S. Universal index. The fund tracks a broad Barclays index of USD-denominated taxable bonds. The index is market value weighted. IUSB was launched on Jun 10, 2014 and is managed by BlackRock. Further Reading Want to see what other hedge funds are holding IUSB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Core Total USD Bond Market ETF ( NASDAQ:IUSB – Free Report ). Receive News & Ratings for iShares Core Total USD Bond Market ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Core Total USD Bond Market ETF and related companies with MarketBeat.com's FREE daily email newsletter .
WASHINGTON -- White House says at least eight US telecom firms, dozens of nations impacted by China hacking campaign.
H&M REOPENS ICONIC TIMES SQUARE FLAGSHIP IN NEW YORK CITY AS NEW BRAND SHOWCASEINDIANAPOLIS (AP) — Jared Goff and the Detroit Lions spent three months scoring at a historic rate. Now with the weather changing outside, they’re winning with old school football, too. Jahmyr Gibbs rushed for two scores , David Montgomery added a third TD run and Detroit's increasingly stingy defense kept the Indianapolis Colts out of the end zone on Sunday, leading the Lions to their ninth straight win, 24-6. “This is, whatever it is, 10 quarters without allowing a touchdown and the three last games in the second half we're not allowing it,” coach Dan Campbell said. “We talk about it all the time — limiting points, play physical style, shut down the run — we were able to do that.” They've been doing it all season in their greatest run in decades, but have been more effective lately and it has shown. The Lions improved to 10-1 for the first time since 1934, their inaugural season in the Motor City. They own the league's longest active winning streak and are 6-0 on the road this season. While the Lions have scored points by the dozens all season, Campbell's preference for physical football means they're equally capable of grinding out wins with the combination of a ball-control offense and an ascending defense that propelled them to this win. Gibbs finished with 21 carries for 90 yards on a day Goff went 26 of 36 with 269 yards and no touchdowns. And for the third straight week, all against AFC South foes, the Lions had a second-half shutout. “If you can win on the road, you're normally a pretty damn good team,” Campbell said. “And we can win on the road.” The Colts (5-7) found out the hard way by losing their second straight home game and for the fourth time in their past five games. Anthony Richardson had another up-and-down game , going 11 of 28 with 172 yards while rushing 10 times for 61 yards. But it was Indy's inability to finish drives with touchdowns that again cost the team. That flaw was evident right from the start when Richardson took the Colts inside the Lions 5-yard line on the game's first series and settled for a short field goal when they couldn't punch it in. “We've got to take advantage of our opportunities,” Colts coach Shane Steichen said. “This league comes down to inches, it comes down to yards and you've got to take advantage of those opportunities. We've had issues down in the red zone and you have to look at the tape and clean it up.” Detroit made Indy pay dearly for its offensive miscues. Gibbs' 1-yard TD run on the Lions' second series made it 7-3 early in the second quarter and after Indy settled for another short field goal, Montgomery spun his way across the goal line for a 6-yard TD and a 14-6 lead. Detroit's defense made sure that was all the scoring punch it needed. “Those players, we've been around each other long enough, they've been around each other to know exactly what we're looking for,” Campbell said. “We have an identity about us. We know the critical factors as they pertain to winning, and those guys take that stuff serious.” Gibbs' 5-yard TD run late in the third quarter gave Detroit a 21-6 lead and they closed it out with a 56-yard field goal midway through the fourth. Amon-Ra St. Brown caught six passes for 62 yards for Detroit while Michael Pittman Jr. had six catches for 96 yards for Indy despite leaving briefly in the first half with an injured shoulder. Gibbs' first score extended Detroit's league record to 25 consecutive games with a TD run, including the playoffs. He's also the third Lions player with 1,000 scrimmage yards and 10 TDs in each of his first two pro seasons with Detroit, joining Billy Sims and Barry Sanders. Gibbs and Montgomery have each scored at least one TD in the same game nine times. Lions: Things got ugly during a third-quarter flurry. Receiver-punt returner Kalif Raymond (foot), left tackle Taylor Decker (right leg) and Montgomery (shoulder) all left in quick succession. Raymond and Montgomery did not return. Decker did. CB Carlton Davis II left early in the fourth with what appeared to be a left knee injury. Colts: Indy deactivated left tackle Bernhard Raimann (knee), forcing the Colts to again use three rookie linemen. Receivers Ashton Dulin (ankle) and Josh Downs (shoulder) both left in the second half. Downs returned, Dulin did not. Lions: Host Chicago in its traditional Thanksgiving Day game. Colts: Visit New England next Sunday. AP NFL: https://apnews.com/hub/NFLUnai Emery feels confidence returning after Aston Villa end winless runNone
Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them. The 38-year-old information technology worker from New Mexico had a prescription. Her pharmacy had the drugs in stock. And her health insurance covered all but $25 to $50 of the monthly cost. For Griffin, the hardest part of using the new drugs wasn’t access. It was finding out that the much-hyped medications didn’t really work for her. “I have been on Wegovy for a year and a half and have only lost 13 pounds,” said Griffin, who watches her diet, drinks plenty of water and exercises regularly. “I’ve done everything right with no success. It’s discouraging.” In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight — up to 50 pounds or more in many cases. But roughly 10% to 15% of patients in those trials were “nonresponders” who lost less than 5% of their body weight. Now that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications. It's a little-known consequence of the obesity drug boom, according to doctors who caution eager patients not to expect one-size-fits-all results. “It's all about explaining that different people have different responses,” said Dr. Fatima Cody Stanford, an obesity expert at Massachusetts General Hospital The drugs are known as GLP-1 receptor agonists because they mimic a hormone in the body known as glucagon-like peptide 1. Genetics, hormones and variability in how the brain regulates energy can all influence weight — and a person's response to the drugs, Stanford said. Medical conditions such as sleep apnea can prevent weight loss, as can certain common medications, such as antidepressants, steroids and contraceptives. “This is a disease that stems from the brain,” said Stanford. “The dysfunction may not be the same” from patient to patient. Despite such cautions, patients are often upset when they start getting the weekly injections but the numbers on the scale barely budge. “It can be devastating,” said Dr. Katherine Saunders, an obesity expert at Weill Cornell Medicine and co-founder of the obesity treatment company FlyteHealth. “With such high expectations, there’s so much room for disappointment.” That was the case for Griffin, who has battled obesity since childhood and hoped to shed 70 pounds using Wegovy. The drug helped reduce her appetite and lowered her risk of diabetes, but she saw little change in weight. “It’s an emotional roller coaster,” she said. “You want it to work like it does for everybody else.” The medications are typically prescribed along with eating behavior and lifestyle changes. It’s usually clear within weeks whether someone will respond to the drugs, said Dr. Jody Dushay, an endocrine specialist at Beth Israel Deaconess Medical Center. Weight loss typically begins right away and continues as the dosage increases. For some patients, that just doesn't happen. For others, side effects such as nausea, vomiting and diarrhea force them to halt the medications, Dushay said. In such situations, patients who were counting on the new drugs to pare pounds may think they’re out of options. “I tell them: It's not game over,” Dushay said. Trying a different version of the new class of drugs may help. Griffin, who didn't respond well to Wegovy, has started using Zepbound, which targets an additional hormone pathway in the body. After three months of using the drug, she has lost 7 pounds. “I'm hoping it's slow and steady,” she said. Other people respond well to older drugs, the experts said. Changing diet, exercise, sleep and stress habits can also have profound effects. Figuring out what works typically requires a doctor trained to treat obesity, Saunders noted. “Obesity is such a complex disease that really needs to be treated very comprehensively,” she said. “If what we’re prescribing doesn’t work, we always have a backup plan.” The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
Conversations with family, friends are critical to estate planning
Former WWE Champion Carmella Provides Unfortunate Injury SetbackTrump nominates cryptocurrency advocate Paul Atkins as SEC chair